Nerve growth factor is associated with islet graft failure following intraportal transplantation

Islets

Volumn 4, Issue 1, 2012, Pages

  Saito, Yukihiko ^a,b   Chan, Nathaniel K ^a   Sakata, Naoaki ^b   Hathout, Eba ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Apoptosis; Diabetes; Intraportal; Islet transplantation; Nerve growth factor

Indexed keywords

GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NERVE GROWTH FACTOR; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GRAFT FAILURE; INTRAPORTAL ISLET TRANSPLANTATION; MOUSE; NONHUMAN; PANCREAS ISLET; PORTAL VEIN; STREPTOZOCIN DIABETES; TRANSPLANTATION;

EID: 84858168383     PISSN: 19382014     EISSN: 19382022     Source Type: Journal    
DOI: 10.4161/isl.4.1.18467     Document Type: Article

References (51)

1. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343:230-8; PMID:10911004; http://dx.doi.org/10.1056/NEJM200007273430401
2. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54:2060-9; PMID: 15983207; http://dx.doi.org/10.2337/diabetes.54.7.2060
3. Koh A, Senior P, SalamA, Kin T, Imes S,Dinyari P, et al. Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success. Transplantation 2010; 89:465-71; PMID:20177350; http://dx.doi.org/10.1097/TP.0b013e3181c478fd
4. Froud T, Ricordi C, Baidal DA, Hafiz MM, Ponte G, Cure P, et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immuno-suppression: Miami experience. Am J Transplant 2005; 5:2037-46; PMID:15996257; http://dx.doi.org/10. 1111/j.1600-6143.2005.00957.x
5. Hering BJ, Kandaswamy R, Ansite JD, Eckman PM, Nakano M, Sawada T, et al. Single-donor, marginaldose islet transplantation in patients with type 1 diabetes. JAMA 2005; 293:830-5; PMID:15713772; http://dx.doi.org/10.1001/jama. 293.7.830
6. Alejandro R, Barton FB, Hering BJ, Wease S. 2008 Update from the Collaborative Islet Transplant Registry. Transplantation 2008; 86:1783-8; PMID:19104422; http://dx.doi.org/10.1097/TP.0b013e3181913f6a
7. Biarnés M, Montolio M, Nacher V, Raurell M, Soler J, Montanya E. Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes 2002; 51:66-72; PMID: 11756324; http://dx.doi.org/10.2337/diabetes.51.1.66
8. Davalli AM, Scaglia L, Zangen DH, Hollister J, Bonner-Weir S, Weir GC. Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 1996; 45:1161-7; PMID:8772716; http://dx.doi.org/10.2337/diabetes.45. 9.1161
9. Mendola JF, Conget I, Manzanares JM, Corominola H, Vinas O, Barcelo J, et al. Follow-up study of the revascularization process of purified rat islet beta-cell grafts. Cell Transplant 1997; 6:603-12; PMID: 9440870; http://dx.doi.org/10.1016/S0963-6897(97) 00099-7
10. MengerMD, Jaeger S,Walter P, Feifel G,Hammersen F, Messmer K. Angiogenesis and hemodynamics of microvasculature of transplanted islets of Langerhans. Diabetes 1989; 38(Suppl 1):199-201; PMID:2463196
11. Miao G, Ostrowski RP, Mace J, Hough J, Hopper A, Peverini R, et al. Dynamic production of hypoxia-inducible factor-1alpha in early transplanted islets. Am J Transplant 2006; 6:2636-43; PMID:17049056; http://dx.doi.org/10. 1111/j.1600-6143.2006.01541.x
12. Moritz W, Meier F, Stroka DM, Giuliani M, Kugelmeier P, Nett PC, et al. Apoptosis in hypoxic human pancreatic islets correlates with HIF-1alpha expression. FASEB J 2002; 16:745-7; PMID:11923216
13. Bradshaw RA, Blundell TL, Lapatto R, McDonald NQ, Murray-Rust J. Nerve growth factor revisited. Trends Biochem Sci 1993; 18:48-52; PMID:8488558; http://dx.doi.org/10.1016/0968-0004(93)90052-O
14. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987; 237:1154-62; PMID:3306916; http://dx.doi.org/10.1126/science.3306916
15. Julio-PieperM, Lozada P, Tapia V, Vega M, Miranda C, Vantman D, et al. Nerve growth factor induces vascular endothelial growth factor expression in granulosa cells via a trkA receptor/mitogen-activated protein kinase-extracellularly regulated kinase 2-dependent pathway. J Clin Endocrinol Metab 2009; 94:3065-71; PMID: 19454577; http://dx.doi.org/10.1210/jc.2009-0542
16. Nico B, Mangieri D, Benagiano V, Crivellato E, Ribatti D. Nerve growth factor as an angiogenic factor. Microvasc Res 2008; 75:135-41; PMID:17764704; http://dx.doi.org/10.1016/j.mvr.2007.07.004
17. Park HJ, Kim MN, Kim JG, Bae YH, Bae MK, Wee HJ, et al. Up-regulation of VEGF expression by NGF that enhances reparative angiogenesis during thymic regeneration in adult rat. Biochim Biophys Acta 2007; 1773:1462-72.
18. Turrini P, Gaetano C, Antonelli A, Capogrossi MC, Aloe L. Nerve growth factor induces angiogenic activity in a mouse model of hindlimb ischemia. Neurosci Lett 2002; 323:109-12; PMID:11950505
19. Cabrera-Vásquez S,Navarro-Tableros V, Sanchez-Soto C, Gutierrez-Ospina G, HiriartM. Remodelling sympathetic innervation in rat pancreatic islets ontogeny. BMC Dev Biol 2009; 9:34; PMID:19534767; http://dx.doi.org/10. 1186/1471-213X-9-34
20. Miao G, Mace J, Kirby M, Hopper A, Peverini R, Chinnock R, et al. In vitro and in vivo improvement of islet survival following treatment with nerve growth factor. Transplantation 2006; 81:519-24; PMID:16495797; http://dx.doi.org/10.1097/01.tp. 0000200320.16723.b3
21. Polak M, Scharfmann R, Seilheimer B, Eisenbarth G, Dressler D, Verma IM, et al. Nerve growth factor induces neuron-like differentiation of an insulin-secreting pancreatic beta cell line. Proc Natl Acad Sci USA 1993; 90:5781-5; PMID:8516328; http://dx.doi. org/10.1073/pnas.90.12.5781
22. Rosenbaum T, Sanchez-Soto MC, Hiriart M. Nerve growth factor increases insulin secretion and barium current in pancreatic beta-cells. Diabetes 2001; 50: 1755-62; PMID:11473035; http://dx.doi.org/10. 2337/diabetes.50.8.1755
23. Hussey AJ, Winardi M, Wilson J, Forster N, Morrison WA, Penington AJ, et al. Pancreatic islet transplantation using vascularised chambers containing nerve growth factor ameliorates hyperglycaemia in diabetic mice. Cells Tissues Organs 2010; 191:382-93; PMID: 20090306; http://dx.doi.org/10.1159/000276595
24. Gezginci-Oktayoglu S, Bolkent S. 4-Methlycatechol prevents NGF/p75(NTR)-mediated apoptosis via NGF/TrkA system in pancreatic beta cells. Neuropeptides 2011; 45:143-50; PMID:21295348; http://dx.doi.org/10.1016/j.npep. 2011.01.001
25. Gezginci-Oktayoglu S, Sacan O, Yanardag R, Karatug A, Bolkent S. Exendin-4 improves hepatocyte injury by decreasing proliferation through blocking NGF/TrkA in diabetic mice. Peptides 2011; 32:223-31; PMID:21055431; http://dx.doi.org/10.1016/j.peptides. 2010.10.025
26. Larrieta ME, Vital P, Mendoza-Rodriguez A, Cerbon M, Hiriart M. Nerve growth factor increases in pancreatic beta cells after streptozotocin-induced damage in rats. Exp Biol Med (Maywood) 2006; 231:396-402; PMID:16565435
27. Frossard N, Freund V, Advenier C. Nerve growth factor and its receptors in asthma and inflammation. Eur J Pharmacol 2004; 500:453-65; PMID:15464052; http://dx.doi.org/10.1016/j.ejphar.2004.07.044
28. Micera A, Puxeddu I, Aloe L, Levi-Schaffer F. New insights on the involvement of nerve growth factor in allergic inflammation and fibrosis. Cytokine Growth Factor Rev 2003; 14:369-74; PMID:12948520; http://dx.doi.org/10. 1016/S1359-6101(03)00047-9
29. Bonini S, Rasi G, Bracci-Laudiero ML, Procoli A, Aloe L. Nerve growth factor: neurotrophin or cytokine? Int Arch Allergy Immunol 2003; 131:80-4; PMID: 12811015; http://dx.doi.org/10.1159/000070922
30. Takei Y, Laskey R. Interpreting crosstalk between TNF-alpha and NGF: potential implications for disease. Trends Mol Med 2008; 14:381-8; PMID: 18693138; http://dx.doi.org/10.1016/j.molmed.2008. 07.002
31. Braun A, Appel E, Baruch R, Herz U, Botchkarev V, Paus R, et al. Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma. Eur J Immunol 1998; 28:3240-51; PMID:9808193; http://dx.doi.org/10.1002/(SICI) 1521-4141(199810) 28:10〈3240::AID-IMMU3240〉3.0.CO;2-U
32. Ehrhard PB, Ganter U, Stalder A, Bauer J, Otten U. Expression of functional trk protooncogene in human monocytes. Proc Natl Acad Sci USA 1993; 90:5423-7; PMID:8390664; http://dx.doi.org/10.1073/pnas.90. 12.5423
33. Lambiase A, Bracci-Laudiero L, Bonini S, Starace G, D'Elios MM, De Carli M, et al. Human CD4+ T cell clones produce and release nerve growth factor and express high-affinity nerve growth factor receptors. J Allergy Clin Immunol 1997; 100:408-14; PMID: 9314355; http://dx.doi.org/10.1016/S0091-6749(97) 70256-2
34. Santambrogio L, Benedetti M, Chao MV, Muzaffar R, Kulig K, Gabellini N, et al. Nerve growth factor production by lymphocytes. J Immunol 1994; 153:4488-95; PMID:7963523
35. Torcia M, Bracci-Laudiero L, Lucibello M, Nencioni L, Labardi D, Rubartelli A, et al. Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 1996; 85:345-56; PMID:8616890; http://dx.doi. org/10.1016/S0092-8674(00)81113-7
36. Barouch R, Appel E, Kazimirsky G, Brodie C. Macrophages express neurotrophins and neurotrophin receptors. Regulation of nitric oxide production by NT-3. J Neuroimmunol 2001; 112:72-7; PMID: 11108935; http://dx.doi.org/10. 1016/S0165-5728(00) 00408-2
37. Ricci A, Greco S, Mariotta S, Felici L, Amenta F, Bronzetti E. Neurotrophin and neurotrophin receptor expression in alveolar macrophages: an immunocytochemical study. Growth Factors 2000; 18:193-202; PMID:11334055; http://dx.doi.org/10.3109/08977190009003244
38. Päth G, Braun A, Meents N, Kerzel S, Quarcoo D, Raap U, et al. Augmentation of allergic early-phase reaction by nerve growth factor. Am J Respir Crit Care Med 2002; 166:818-26; PMID:12231491; http://dx. doi.org/10.1164/rccm.200202-134OC
39. Mazurek N, Weskamp G, Erne P, Otten U. Nerve growth factor induces mast cell degranulation without changing intracellular calcium levels. FEBS Lett 1986; 198:315-20; PMID:2420641; http://dx.doi.org/10. 1016/0014-5793(86)80428-8
40. Crispe IN. The liver as a lymphoid organ. Annu Rev Immunol 2009; 27:147-63; PMID:19302037; http://dx.doi.org/10.1146/annurev.immunol.021908. 132629
41. Gao B, Jeong WI, Tian Z. Liver: An organ with predominant innate immunity. Hepatology 2008; 47:729-36; PMID:18167066; http://dx.doi.org/10. 1002/hep.22034
42. Ishiyama K, Rawson J, Omori K, Mullen Y. Liver natural killer cells play a role in the destruction of islets after intraportal transplantation. Transplantation 2011; 91:952-60; PMID:21389902; http://dx.doi.org/10. 1097/TP.0b013e3182139dc1
43. Barshes NR, Wyllie S, Goss JA. Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts. J Leukoc Biol 2005; 77:587-97; PMID:15728243; http://dx.doi.org/10.1189/ jlb.1104649
44. Yasunami Y, Kojo S, Kitamura H, Toyofuku A, Satoh M, Nakano M, et al. Valpha14 NK T cell-triggered IFN-gamma production by Gr-1+CD11b+ cells mediates early graft loss of syngeneic transplanted islets. J Exp Med 2005; 202:913-8; PMID:16186183; http://dx.doi.org/10.1084/jem.20050448
45. Shimoda M, Chen S, Noguchi H, Matsumoto S, Grayburn PA. In vivo non-viral gene delivery of human vascular endothelial growth factor improves revascularisation and restoration of euglycaemia after human islet transplantation into mouse liver. Diabetologia 2010; 53:1669-79; PMID:20405100; http://dx. doi.org/10.1007/s00125-010-1745-5
46. Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L. Signal transduction by vascular endothelial growth factor receptors. Biochem J 2011; 437:169-83; PMID: 21711246; http://dx.doi.org/10.1042/BJ20110301
47. Zhang J, Silva T, Yarovinsky T, Manes TD, Tavakoli S, Nie L, et al. VEGF blockade inhibits lymphocyte recruitment and ameliorates immune-mediated vascular remodeling. Circ Res 2010; 107:408-17; PMID: 20538685; http://dx.doi.org/10.1161/CIRCRESAHA. 109.210963
48. Gotoh M, Maki T, Kiyoizumi T, Satomi S, Monaco AP. An improved method for isolation of mouse pancreatic islets. Transplantation 1985; 40:437-8; PMID:2996187; http://dx.doi.org/10.1097/00007890-198510000-00018
49. Yonekawa Y, Okitsu T, Wake K, Iwanaga Y, Noguchi H, Nagata H, et al. A new mouse model for intraportal islet transplantation with limited hepatic lobe as a graft site. Transplantation 2006; 82:712-5; PMID:16969298; http://dx.doi.org/10.1097/01.tp.0000234906.29193.a6
50. Lee BW, Lee M, Chae HY, Lee S, Kang JG, Kim CS, et al. Effect of hypoxia-inducible VEGF gene expression on revascularization and graft function in mouse islet transplantation. Transpl Int 2011; 24:307-14; PMID:21138485; http://dx.doi.org/10.1111/j.1432-2277.2010.01194.x
51. Zhang N, Richter A, Suriawinata J, Harbaran S, Altomonte J, Cong L, et al. Elevated vascular endothelial growth factor production in islets improves islet graft vascularization. Diabetes 2004; 53:963-70; PMID:15047611; http://dx.doi.org/10.2337/diabetes.53.4.963